Approval · Notice of Compliance 18450 · 2016
ERFA-TRANEXAMIC: Notice of Compliance 18450
Issued September 6, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18450
- Date
- September 6, 2016
- Company
- Erfa Canada 2012 Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- CYKLOKAPRON (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERFA-TRANEXAMIC | 02457431 | Cancelled Post Market |
Medicinal ingredients
- TRANEXAMIC ACID 100 MG per ML